Joslin scientists find that salsalate lowers blood glucose in type 2 diabetes

Common pain reliever may provide a new medication option to treat type 2 diabetes

2013-07-02

(Press-News.org) BOSTON – July 1, 2013 -- Joslin scientists report that salsalate, a drug used to treat arthritis, lowers blood glucose and improves glycemic control in type 2 diabetes. These findings, which were published today by the Annals of Internal Medicine, provide additional evidence that salsalate may be an effective drug to treat type 2 diabetes.

The scientists became interested in studying salsalate, an anti-inflammatory drug, after research conducted by Steven Shoelson, M.D., Ph.D., Head of the Section on Pathophysiology and Molecular Pharmacology and Professor of Medicine at Harvard Medical School, identified inflammation as a factor in the development of type 2 diabetes.

Stage 1 of TINSAL-T2D (Targeting Inflammation Using Salsalate in Type 2 Diabetes) evaluated varying doses of salsalate in 108 participants with type 2 diabetes for 14 weeks. This study was reported in the Annals of Internal Medicine in 2010. The current findings are based on Stage 2 of TINSAL-T2D, which evaluated 286 participants with type 2 diabetes for 48 weeks. The subjects' blood glucose was inadequately controlled on current diabetes medications. Participants were randomized into salsalate and placebo groups.

After 48 weeks of treatment, the mean hemoglobin A1c level (a measurement of average blood glucose control over the past six to twelve weeks) was 37 percent lower in the salsalate group compared to the placebo group. The decrease in fasting glucose concentration was 15 mg/dl greater in the salsalate group than the placebo group. Patients in the salsalate group required fewer additional diabetes medications to control their blood sugar than patients in the placebo group.

"It's exciting that salsalate is effective in lowering blood sugar," says Allison Goldfine, M.D., lead author and Head of the Section of Clinical, Behavioral and Outcomes Research, and an Associate Professor of Medicine at Harvard Medical School. "Salsalate may have an important role in diabetes treatment and may also help us learn more about how inflammation contributes to the development of type 2 diabetes."

The salsalate group also showed improvements in markers associated with coronary risk: a 9 percent reduction in triglycerides and a 27 percent increase in adiponectin, a potentially cardioprotective protein from adipocytes. Uric acid, which is associated with cardiometabolic conditions and progression of renal disease, decreased 18 percent in the salsalate group. "The reductions in these cardiovascular risk factors paralleled improved glycemia," says Dr. Goldfine. However, the salsalate group also exhibited modest increases in LDL cholesterol and urine albumin, and had a slight increase in weight, which can indicate negative effects on heart or kidney function.

Salsalate's anti-inflammatory effects were evidenced by reductions in circulating white blood cells, neutrophils and lymphocytes, which are elevated in obesity and metabolic syndrome, but all remained within normal range.

The next step in determining whether salsalate is a safe drug for use as a diabetes medication and can receive FDA approval is to assess its effects on the progression of heart disease. Dr. Goldfine is currently leading a study, TINSAL-CVD, which is evaluating how salsalate affects coronary artery plaque volume in participants with established coronary artery disease. The results should be available in two years. "The study will help us better understand the risk/benefit ratio of using salsalate to treat diabetes," says Dr. Goldfine.

INFORMATION:

TINSAL-T2D was funded by the National Institutes of Health.

About Joslin Diabetes Center

Joslin Diabetes Center, located in Boston, Massachusetts, is the world's largest diabetes research and clinical care organization. Joslin is dedicated to ensuring that people with diabetes live long, healthy lives and offers real hope and progress toward diabetes prevention and a cure. Joslin is an independent, nonprofit institution affiliated with Harvard Medical School.

Our mission is to prevent, treat and cure diabetes. Our vision is a world free of diabetes and its complications. For more information, visit http://www.joslin.org.

About Joslin Research

Joslin Research comprises the most comprehensive and productive effort in diabetes research under one roof anywhere in the world. With 30-plus faculty-level investigators and an annual research budget of $36 million, Joslin researchers focus on unraveling the biological, biochemical and genetic processes that underlie the development of type 1 and type 2 diabetes and related complications.

Joslin research is highly innovative and imaginative, employing the newest tools in genetics, genomics and proteomics to identify abnormalities that may play a role in the development of diabetes and its complications. Joslin Clinic patients, and others with diabetes, have the option of participating in clinical trials at Joslin to help translate basic research into treatment innovations.

Joslin has one of the largest diabetes training programs in the world, educating 150 M.D. and Ph.D. researchers each year, many of whom go on to head diabetes initiatives at leading institutions all over the globe. For more information, visit http://www.joslinresearch.org.

ELSE PRESS RELEASES FROM THIS DATE:

Hijacking stress response in cancer

2013-07-02

Cancer cells have alteration in metabolic pathways as a result of oncogenes that promote tumor growth. NRF2 (nuclear factor erythroid-derived 2-related factor 2) works as a "master gene" that turns on stress response by increasing numerous antioxidants and pollutant-detoxifying genes to protect the lungs from variety of air pollutants such as diesel exhaust and cigarette smoke. However, researchers at the Johns Hopkins Bloomberg School of Public Health and others have found for the first time that NRF2 signaling also plays a role in the growth of tumor cells by altering ...

Dissecting the distinctive walk of disease

2013-07-02

PITTSBURGH -- Older adults diagnosed with brain disorders such as Parkinson's disease often feel a loss of independence because of their lack of mobility and difficulty walking. To better understand and improve these mobility issues—and detect them sooner—a University of Pittsburgh multidisciplinary research team is working toward building a more advanced motion test that addresses a wider range of walking patterns and movements. In a recent issue of IEEE Transactions on Neural Systems and Rehabilitation Engineering, researchers from Pitt's Swanson School of Engineering, ...

NASA sees tropical storm dalila weaken, new low pressure area form

2013-07-02

NOAA's GOES-15 satellite captured an infrared image of the Eastern Pacific Ocean during the pre-dawn hours on July 2 and noticed Tropical Storm Dalila weakening near the southwestern Mexico coast, while further southwest a new tropical low pressure area called System 97E, had formed. Dalila's maximum sustained winds appeared to peak on July 1 at 11 p.m. EDT when they hit 70 mph (110 kph). By 5 a.m. EDT on July 2, Dalila's maximum sustained winds dropped to 65 mph (100 kph). Dalila was also moving away from the southwestern coast of Mexico and headed into the open waters ...

Don't judge by the looks: Molecular analysis reveals a new species of white toothed shrew

2013-07-02

The white toothed shrew genus Crocidura is known as the largest mammal genus, with more than 180 species distributed around the world. A recent genetic analysis of the white toothed shrew fauna of Vietnam revealed the misinterpretations of previous morphological studies of the species, including the description of a new species of these very small mammals. The study was published in the open access journal ZooKeys. Describing new mammal species is an unusual event nowadays when mammal fauna has been by and large already thoroughly studied by zoologists during the previous ...

High nitrogen dioxide levels from Arizona's Yarnell Hill Fire

2013-07-02

This June 29, 2013 image from the OMI, or Ozone Monitoring Instrument aboard NASA's Aura satellite shows nitrogen dioxide (NO2) levels in Arizona pertaining to three large fires. The highest levels of NO2, which is produced by combustion, were from the Yarnell Hill fire (dark red and brown). NO2 concentration is given as the number of molecules in a cubic centimeter. The highest NO2 concentration values (8-9 x 10^15) indicated that this strong fire was burning a large amount of combustible material and thus generating a large amount of NO2 in a small area. The image was ...

AGU journal highlights -- 2 July 2013

2013-07-02

The following highlights summarize research papers that have been recently published in Geophysical Research Letters (GRL) and Journal of Geophysical Research-Solid Earth (JGR-B). In this release: Past decade saw unprecedented warming in the deep ocean Hurricanes could increase over western Europe as climate warms Space traffic may be cause of increase in polar mesospheric clouds Tropical storm Sandy was a one-in-700 year event German records from 1920s show long-term ocean warming Identifying slow slip events with GNSS Anyone may read the scientific ...

Weekly yoga class yields similar lower back pain relief as 2 classes

2013-07-02

(Boston) – Researchers at Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) have found that a weekly yoga class provided similar lower back pain relief and reduced the need for pain medication as twice weekly classes in lower income minority patients. The results of the study indicate that patients interested in trying yoga for lower back pain could benefit from attending a medically appropriate weekly yoga class. The study, published in Evidence-Based Complementary and Alternative Medicine, was led by first author Robert Saper, MD, MPH, associate ...

Greenhouse gas likely altering ocean foodchain

2013-07-02

Climate change may be weeding out the bacteria that form the base of the ocean's food chain, selecting certain strains for survival, according to a new study. In climate change, as in everything, there are winners and losers. As atmospheric carbon dioxide levels and temperature rise globally, scientists increasingly want to know which organisms will thrive and which will perish in the environment of tomorrow. The answer to this question for nitrogen-fixing cyanobacteria (bacteria that obtain energy through photosynthesis, or "blue-green algae") turns out to have implications ...

23andMe and ALSPAC identify 16 new genetic associations for pollen, dust-mite and cat allergies

2013-07-02

Mountain View, Calif. – The largest genome-wide association study ever conducted on common allergies, including pollen, dust-mite and cat allergies, has identified 16 new genetic associations related to the condition. The study, conducted in collaboration between 23andMe, the leading personal genetics company, and the Avon Longitudinal Study of Parents and Children (ALSPAC), examined data for more than 53,000 individuals. The study also identified eight genetic variations for allergies that have previously been associated with asthma. Genes implicated in the study highlight ...

NASA sees Tropical Storm Rumbia hit China with heavy rainfall

2013-07-02

VIDEO: This NASA TRMM satellite 3-D flyby of tropical storm Rumbia showed that the thunderstorms near the center of circulation were below 13 km (~8.1 miles). Rainfall was occurring at... Click here for more information. Typhoon Rumbia had weakened to a tropical storm and moved over southern China when NASA's TRMM satellite flew above on July 2, 2013 at 0316 UTC and measured its rainfall rates. An analysis of rainfall from TRMM Microwave Imager (TMI) and Precipitation (PR) ...

Joslin scientists find that salsalate lowers blood glucose in type 2 diabetes

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: